Release Date: 11/10/19 12:26 Summary: 2019 Corporate Governance Statement Price Sensitive: No Download Document 238.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%